Comparative antimicrobial spectrum and activity of the desfluoroquinolone BMS28475 (T-3811) tested against non-fermentative Gram-negative bacilli

Clinical Microbiology and Infection

Volumn 8, Issue 6, 2002, Pages 340-344

  Howard, W ^b   Biedenbach, D J ^b   Jones, R N ^a  

^a JMI LABORATORIES   (United States)

^b NONE

Author keywords

Acinetobacter spp.; BMS284756; Burkholderia spp.; E test; Pseudomonas aeruginosa; Stenotrophomonas maltophilia

Indexed keywords

CIPROFLOXACIN; GARENOXACIN; GATIFLOXACIN; GEMIFLOXACIN; LEVOFLOXACIN; QUINOLONE DERIVATIVE;

ACCURACY; ACINETOBACTER; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BURKHOLDERIA; CONTROLLED STUDY; CULTURE MEDIUM; DRUG POTENCY; DRUG SURVEILLANCE PROGRAM; GRAM NEGATIVE BACTERIUM; IN VITRO STUDY; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STENOTROPHOMONAS; STRAIN DIFFERENCE;

ACINETOBACTER; BACILLI; BACTERIA (MICROORGANISMS); BURKHOLDERIA; NEGIBACTERIA; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; STENOTROPHOMONAS; STENOTROPHOMONAS MALTOPHILIA;

EID: 0036592477     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2002.00399.x     Document Type: Article

References (17)

1. Survey of blood stream infections due to Gram-negative bacilli. Frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Program, 1997
2. Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY Antimicrobial Surveillance Program, 1997 and 1998
3. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1999-May.1999, issue June 1999
4. Survey of blood stream infections attributable to Gram-positive cocci: Frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from Antimicrobial Surveillance Program
5. Anti-microbial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia: Analysis of results from the SENTRY Antimicrobial Surveillance Program (1997)
6. In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-f(6)-quinolone
7. Anti-bacterial spectrum of a novel des-fluoro(6) quinolone, BMS 284756
8. Comparative in vitro activity of gatifloxacin against Stenotrophomonas maltophilia and Burkholderia species isolates including evaluation of disk diffusion and Etest methods
9. Burkholderia, Stenotrophomonas, Ralstonia, Brevondimonas, Comamonas, and Acitovorax
10. Pseudomonas
11. Acinetobacter, Alcaligenes, Moraxella, Methylobacterium, and other non-fermentative Gram-negative rods
12. Evaluation of current activities of fluoroquinolones against Gram-negative bacilli using centralized in vitro testing and electronic surveillance
13. Nonrespiratory Stenotrophomonas maltophilia infection at a children's hospital